1.The current state of systemic lupus erythematosus care in the Philippines: a narrative review
Juan Raphael M. PEREZ ; Genquen Philip CARADO ; Christian Luke D.C. BADUA ; Maria Victoria V. CU ; Gerinne N. DAQUIOAG ; Vinzyl Clarisse L. DIMOL ; Frances Dominique V. HO ; Geraldine T. ZAMORA-ABRAHAN ; Ourlad Alzeus G. TANTENGCO
Journal of Rheumatic Diseases 2026;33(2):73-85
Systemic lupus erythematosus (SLE) is a multisystemic autoimmune disease of clinical importance in the Philippines. While its actual prevalence in the Philippines is unknown due to a lack of organized cohorts and community-level screening, Filipino females in the second and third decades of life are primarily affected, commonly presenting with mucocutaneous, musculoskeletal, hematologic, and renal involvements. Several risk factors have been described as influencing the development of SLE in Filipinos, including molecular/genetic, clinical, lifestyle, and environmental factors. The diagnosis of SLE in the Philippines still relies on international standards, such as the Systemic Lupus International Collaborating Clinics 2012 and the European League Against Rheumatism/American College of Rheumatology 2019 classification criteria. Similarly, the lack of published local guidelines for SLE requires Filipino practitioners to rely on international management guidelines, which now include the Asia-Pacific League of Associations for Rheumatology recommendations for the Asia-Pacific region, with management goals including the achievement of a low disease activity state, the prevention of organ damage, the prevention of flares, and the promotion of quality of life. Structural barriers still impede comprehensive lupus care in the country, manifesting as poor access to essential drugs and rheumatologists, low capacity for community-level surveillance, lacking research and guidelines in Philippine-specific nuances (i.e., common presentations and comorbidities such as tuberculosis), and education. The medical community in the country must be mobilized to ensure holistic care for SLE patients, as it is one of the most important rheumatologic conditions in the Philippines.
2.Salmonella in Malaysia: Outbreaks, contamination sources, serovar distribution and antimicrobial resistance patterns
Tropical Biomedicine 2026;43(No. 1):112-131
Salmonella is one of the leading causes of foodborne illnesses worldwide, with the ability to contaminate
a wide range of sources. The identification of the frequently contaminated sources is vital for improving
the management of Salmonella infections and outbreaks. As there is growing concern on bacterial
resistance to antimicrobial agents globally, it is crucial to monitor the resistance of Salmonella to
antimicrobial agents for effective treatment of salmonellosis and prudent use of antibiotics. The
epidemiology of Salmonella, including outbreak patterns, serovars prevalence and antimicrobial
resistance profiles, could differ by region. Therefore, assessing the local status of Salmonella is crucial
for implementing targeted interventions. This review provides an overview of foodborne disease and
Salmonella-related outbreaks in Malaysia, focusing on Salmonella’s sources of isolation, serovars and
antimicrobial resistance patterns. In Malaysia, food poisoning outbreaks remain a recurring public health
issue, and Salmonella is one of the main causative agents with fatal cases. However, the true burden of
salmonellosis is difficult to determine as data on non-typhoidal salmonellosis are lacking. Salmonella was
detected in both human and non-human samples, with S. Typhimurium and S. Enteritidis being the most
common serovars. Salmonella isolates in Malaysia exhibited a wide range of antimicrobial susceptibility
patterns, with notably high resistance to erythromycin and penicillin. The review highlights the need
for continuous surveillance of Salmonella infections, encompassing both typhoidal and non-typhoidal
salmonellosis, as well as systematic monitoring of contamination sources and antimicrobial resistance
patterns to improve understanding and ensure effective management of salmonellosis in Malaysia.
3.Predictors of Outcome in Management of Paediatric Head Trauma in a Tertiary Healthcare Institution in North-Central Nigeria
Gyang Markus BOT ; Danaan J. SHILONG ; Jerry A. PHILIP ; Ezekiel Dido DUNG ; Andrew H. SHITTA ; Nanpan Isa KYESMEN ; Jeneral D. ALFIN ; Lena Mary HOULIHAN ; Mark C. PREUL ; Kenneth N. OZOILO ; Peter O. BINITIE
Journal of Korean Neurosurgical Society 2023;66(5):582-590
Objective:
: Trauma is a leading causes of death and disability in all ages. The aim of this study was to describe the demography and characteristics of paediatric head trauma in our institution and examine the predictors of outcome and incidence of injury related mortality.
Methods:
: We examined our institutional Trauma Registry over a 2 year period.
Results:
: A total of 1100 trauma patients were seen over the study period. Of the 579 patients who had head injury 99 were in the paediatric age group. Of the paediatric head trauma patients 79 had documented Glasgow coma score (GCS), 38 (48.1%), 17 (21.5%) and 24 (30.4%) had mild, moderate and severe head injury respectively. The percentage mortality of head injury in the paediatric age group was 6.06% (6/99). There is an association between mortality and GCS (p=0.008), necessity for intensive care unit (ICU) admission (p=0.0001), associated burns (p=0.0001) and complications such as aspiration pneumonia (p=0.0001). The significant predictors of outcome are aspiration (p=0.004), the need for ICU admission (p=0.0001) and associated burns (p=0.005) using logistic binary regression. During the study period 46 children underwent surgical intervention with extradural haematoma 16 (34.8%), depressed skull fracture 14 (30.4%) and chronic subdural haematoma five (10.9%) being the commonest indication for surgeries.
Conclusion
: Paediatric head injury accounted for 9.0% (99/1100) of all trauma admissions. Majority of patients had mild or moderate injuries. Burns, aspiration pneumonitis and the need for ICU admission were important predictors of outcome in children with traumatic brain injury.
4.Modeling Human Gonad Development in Organoids
Marina V. PRYZHKOVA ; Romina BOERS ; Philip W. JORDAN
Tissue Engineering and Regenerative Medicine 2022;19(6):1185-1206
BACKGROUND:
Our learning about human reproductive development is greatly hampered due to the absence of an adequate model. Animal studies cannot truthfully recapitulate human developmental processes, and studies of human fetal tissues are limited by their availability and ethical restrictions. Innovative three-dimensional (3D) organoid technology utilizing human pluripotent stem cells (hPSCs) offered a new approach to study tissue and organ development in vitro. However, a system for modeling human gonad development has not been established, thus, limiting our ability to study causes of infertility.
METHODS:
In our study we utilized the 3D hPSC organoid culture in mini-spin bioreactors. Relying on intrinsic selforganizing and differentiation capabilities of stem cells, we explored whether organoids could mimic the development of human embryonic and fetal gonad.
RESULTS:
We have developed a simple, bioreactor-based organoid system for modeling early human gonad development. Male hPSC-derived organoids follow the embryonic gonad developmental trajectory and differentiate into multipotent progenitors, which further specialize into testicular supporting and interstitial cells. We demonstrated functional activity of the generated cell types by analyzing the expression of cell type-specific markers. Furthermore, the specification of gonadal progenitors in organoid culture was accompanied by the characteristic architectural tissue organization.
CONCLUSION
This organoid system opens the opportunity for detailed studies of human gonad and germ cell development that can advance our understanding of sex development disorders. Implementation of human gonad organoid technology could be extended to modeling causes of infertility and regenerative medicine applications.
5.Colitis and Crohn’s Foundation (India): a first nationwide inflammatory bowel disease registry
Ajit SOOD ; Kirandeep KAUR ; Ramit MAHAJAN ; Vandana MIDHA ; Arshdeep SINGH ; Sarit SHARMA ; Amarender Singh PURI ; Bhabhadev GOSWAMI ; Devendra DESAI ; C. Ganesh PAI ; Kiran PEDDI ; Mathew PHILIP ; Rakesh KOCHHAR ; Sandeep NIJHAWAN ; Shobna BHATIA ; N. Sridhara RAO
Intestinal Research 2021;19(2):206-216
Background/Aims:
The national registry for inflammatory bowel disease (IBD) was designed to study epidemiology and prescribing pattern of treatment of IBD in India.
Methods:
A multicenter, cross-sectional, prospective registry was established across four geographical zones of India. Adult patients with ulcerative colitis (UC) or Crohn’s disease (CD) were enrolled between January 2014 and December 2015. Information related to demographics; disease features; complications; and treatment history were collected and analyzed.
Results:
A total of 3,863 patients (mean age, 36.7 ± 13.6 years; 3,232 UC [83.7%] and 631 CD [16.3%]) were enrolled. The majority of patients with UC (n = 1,870, 57.9%) were from north, CD was more common in south (n = 348, 55.5%). The UC:CD ratio was 5.1:1. There was a male predominance (male:female = 1.6:1). The commonest presentation of UC was moderately severe (n = 1,939, 60%) and E2 disease (n = 1,895, 58.6%). Patients with CD most commonly presented with ileocolonic (n = 229, 36.3%) inflammatory (n = 504, 79.9%) disease. Extraintestinal manifestations were recorded among 13% and 20% of patients in UC and CD respectively. Less than 1% patients from both cohorts developed colon cancer (n = 26, 0.7%). The commonly used drugs were 5-aminosalicylates (99%) in both UC and CD followed by azathioprine (34.4%). Biologics were used in only 1.5% of patients; more commonly for UC in north and CD in south.
Conclusions
The national IBD registry brings out diversities in the 4 geographical zones of India. This will help in aiding research on IBD and improving quality of patient care.
6.Colitis and Crohn’s Foundation (India): a first nationwide inflammatory bowel disease registry
Ajit SOOD ; Kirandeep KAUR ; Ramit MAHAJAN ; Vandana MIDHA ; Arshdeep SINGH ; Sarit SHARMA ; Amarender Singh PURI ; Bhabhadev GOSWAMI ; Devendra DESAI ; C. Ganesh PAI ; Kiran PEDDI ; Mathew PHILIP ; Rakesh KOCHHAR ; Sandeep NIJHAWAN ; Shobna BHATIA ; N. Sridhara RAO
Intestinal Research 2021;19(2):206-216
Background/Aims:
The national registry for inflammatory bowel disease (IBD) was designed to study epidemiology and prescribing pattern of treatment of IBD in India.
Methods:
A multicenter, cross-sectional, prospective registry was established across four geographical zones of India. Adult patients with ulcerative colitis (UC) or Crohn’s disease (CD) were enrolled between January 2014 and December 2015. Information related to demographics; disease features; complications; and treatment history were collected and analyzed.
Results:
A total of 3,863 patients (mean age, 36.7 ± 13.6 years; 3,232 UC [83.7%] and 631 CD [16.3%]) were enrolled. The majority of patients with UC (n = 1,870, 57.9%) were from north, CD was more common in south (n = 348, 55.5%). The UC:CD ratio was 5.1:1. There was a male predominance (male:female = 1.6:1). The commonest presentation of UC was moderately severe (n = 1,939, 60%) and E2 disease (n = 1,895, 58.6%). Patients with CD most commonly presented with ileocolonic (n = 229, 36.3%) inflammatory (n = 504, 79.9%) disease. Extraintestinal manifestations were recorded among 13% and 20% of patients in UC and CD respectively. Less than 1% patients from both cohorts developed colon cancer (n = 26, 0.7%). The commonly used drugs were 5-aminosalicylates (99%) in both UC and CD followed by azathioprine (34.4%). Biologics were used in only 1.5% of patients; more commonly for UC in north and CD in south.
Conclusions
The national IBD registry brings out diversities in the 4 geographical zones of India. This will help in aiding research on IBD and improving quality of patient care.
7.Environmental sampling for SARS-CoV-2 at a reference laboratory and provincial hospital in central Viet Nam, 2020
Thá ; i Hù ; ng Đỗ ; Văn Thà ; nh Nguyễn ; Thế Hù ; ng Đinh ; Xuâ ; n Huy Lê ; ; Quang Chiê ; u Nguyễn ; Văn Quâ ; n Lê ; ; Bảo Triệu Nguyễn ; Ngọc Bí ; ch Ngâ ; n Nguyễn ; Thị Ngọc Phú ; c Nguyễn ; Kim Mai Huỳnh ; Hoà ; ng Long Trịnh ; Thị Kim Trang Lê ; ; Thù ; y Dung Diệp ; Thủy Thị Thu Đỗ ; Hiền Thị Thu Bù ; i ; Alyssa M Finlay ; Quốc Việt Nguyễn ; Philip L Gould
Western Pacific Surveillance and Response 2021;12(3):47-55
Objective: To determine whether environmental surface contamination with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) occurred at a provincial hospital in Viet Nam that admitted patients with novel coronavirus disease 2019 (COVID-19) and at the regional reference laboratory responsible for confirmatory testing for SARS-CoV-2 in 2020.
Methods: Environmental samples were collected from patient and staff areas at the hospital and various operational and staff areas at the laboratory. Specimens from frequently touched surfaces in all rooms were collected using a moistened swab rubbed over a 25 cm2 area for each surface. The swabs were immediately transported to the laboratory for testing by real-time reverse transcription polymerase chain reaction (RT-PCR). Throat specimens were collected from staff at both locations and were also tested for SARS-CoV-2 using real-time RT-PCR.
Results: During the sampling period, the laboratory tested 6607 respiratory specimens for SARS-CoV-2 from patients within the region, and the hospital admitted 9 COVID-19 cases. Regular cleaning was conducted at both sites in accordance with infection prevention and control (IPC) practices. All 750 environmental samples (300 laboratory and 450 hospital) and 30 staff specimens were negative for SARS-CoV-2.
Discussion: IPC measures at the facilities may have contributed to the negative results from the environmental samples. Other possible explanations include sampling late in a patient’s hospital stay when virus load was lower, having insufficient contact time with a surface or using insufficiently moist collection swabs. Further environmental sampling studies of SARS-CoV-2 should consider including testing for the environmental presence of viruses within laboratory settings, targeting the collection of samples to early in the course of a patient’s illness and including sampling of confirmed positive control surfaces, while maintaining appropriate biosafety measures.
8.Clinical management of cerebral small vessel disease: a call for a holistic approach
Una CLANCY ; P. Jason APPLETON ; Carmen ARTEAGA ; N. Fergus DOUBAL ; M. Philip BATH ; M. Joanna WARDLAW
Chinese Medical Journal 2021;134(2):127-142
Cerebral small vessel disease (SVD) is a common global brain disease that causes cognitive impairment, ischemic or hemorrhagic stroke, problems with mobility, and neuropsychiatric symptoms. The brain damage, seen as focal white and deep grey matter lesions on brain magnetic resonance imaging (MRI) or computed tomography (CT), typically accumulates "covertly" and may reach an advanced state before being detected incidentally on brain scanning or causing symptoms. Patients have typically presented to different clinical services or been recruited into research focused on one clinical manifestation, perhaps explaining a lack of awareness, until recently, of the full range and complexity of SVD.In this review, we discuss the varied clinical presentations, established and emerging risk factors, relationship to SVD features on MRI or CT, and the current state of knowledge on the effectiveness of a wide range of pharmacological and lifestyle interventions. The core message is that effective assessment and clinical management of patients with SVD, as well as future advances in diagnosis, care, and treatment, will require a more "joined-up" ’ approach. This approach should integrate clinical expertise in stroke neurology, cognitive, and physical dysfunctions. It requires more clinical trials in order to improve pharmacological interventions, lifestyle and dietary modifications. A deeper understanding of the pathophysiology of SVD is required to steer the identification of novel interventions. An essential prerequisite to accelerating clinical trials is to improve the consistency, and standardization of clinical, cognitive and neuroimaging endpoints.
9.Adaptation of Human Testicular Niche Cells for Pluripotent Stem Cell and Testis Development Research
Marina V. PRYZHKOVA ; Philip W. JORDAN
Tissue Engineering and Regenerative Medicine 2020;17(2):223-235
Background:
Human testicular cells are greatly valuable to the research community as tools for studying testicular physiology and the effects of environmental pollutants. Because adult testicular cells have a limited self-organization capacity and life span, we investigated whether human pluripotent stem cells (hPSCs) can be used together with testicular cells to move a step closer toward making an optimal model of the human testis.
Methods:
We used in vitro culture of donor testicular cells under serum-containing and chemically defined conditions. CRISPR-Cas9 technology was applied to introduce fluorescent transgenes (mCherry2 and EGFP) into hPSCs and testicular cells. hPSC-derived spheroids were co-cultured with human testicular cells in mini-spin bioreactors.
Results:
Traditional cell culture conditions used for maintenance of testicular somatic cells generally contain serum and pose limitations on evaluating the role of active molecules on cell functions. We established that chemically defined culture conditions can be used to maintain testicular cells without the loss of proliferative activity. These cultures demonstrate marker expression which is characteristic of common testicular cell types: Sertoli, Leydig, endothelial, myoid cells, and macrophages. In order to model testicular physiology, it is important to be able to perform live cell microscopy. Thus, we generated fluorescent protein-expressing human testicular cells and hPSCs and demonstrated that these cell types can be successfully co-cultured for prolonged periods of time in a three-dimensional microenvironment.
Conclusion
Our research extends the possible applications of human testis-derived somatic cells and shows that they can be used together with hPSCs for further studies of human male reproductive biology.
10.Changes of cerebral cortical metabolomics in rats following benzoapyrene exposure.
Jing WANG ; Chun-Lin LI ; Lu-Lu BAI ; Qiang-Hu TANG ; Rui-Yuan ZHANG ; Ting-Li HAN ; Yu-Ming GUO ; Philip N BAKER ; Yin-Yin XIA ; Bai-Jie TU
Journal of Southern Medical University 2018;38(2):162-167
OBJECTIVETo analyze the changes in endogenous small molecule metabolites after benzo[a]pyrene (B[a]P) exposure in rat cerebral cortex and explore the mechanism of B[a]P neurotoxicity.
METHODSFive-day-old SD rats were subjected to gavage administration of 2 mg/kg B[a]P for 7 consecutive weeks. After the exposure, the rats were assessed for spatial learning ability using Morris water maze test, ultrastructural changes of the cortical neurons under electron microscope, and metabolite profiles of the cortex using GC/MS. The differential metabolites between the exposed and control rats were identified with partial least squares discriminant analysis (PLS-DA) and the metabolic pathways related with the differential metabolites were analyzed using Cytoscape software.
RESULTSCompared with the control group, the rats exposed to B[a]P showed significantly increased escape latency (P<0.05) and decreased time spent in the target area (P<0.05). The exposed rats exhibited widened synaptic cleft, thickened endplate membrane and swollen cytoplasm compared with the control rats. Eighteen differential metabolites (VIP>1, P<0.05) in the cortex were identified between the two groups, and 9 pathways associated with B[a]P neurotoxicity were identified involving amino acid metabolism, tricarboxylic acid cycle and Vitamin B3 (niacin and nicotinamide) metabolism.
CONCLUSIONB[a]P can cause disturbance in normal metabolisms and its neurotoxicity is possibly related with disorders in amino acid metabolism, tricarboxylic acid cycle and vitamin metabolism.


Result Analysis
Print
Save
E-mail